A method for treating an inflammatory disease or an immune disorder includes administering to a subject in need of such treatment an antagonist against ENO1. The antagonist binds ENO1 and inhibits ENO1 plasminogen receptor activity. The antagonist may be an anti-human ENO1 antibody, or an scFv, Fab, or F(ab)2 fragment thereof, that specifically binds to human ENO1 (GenBank: AAH50642.1) for the treatment of an inflammatory disease or an immune disorder, which may be multiple sclerosis, rheumatoid arthritis, Crohn's disease, ulcerative colitis, systemic Lupus erythematosus, chronic obstructive pulmonary disease (COPD), asthma, allergy, psoriasis, type 1 diabetes mellitus, artherosclerosis or osteoporosis.


    Zugriff

    Download


    Exportieren, teilen und zitieren



    Titel :

    Alpha-enolase specific antibodies and method of use in immune diseases


    Beteiligte:
    TSAI SHIH-CHONG (Autor:in) / CHANG MINGL (Autor:in) / YUAN TA-TUNG (Autor:in) / TSENG SHIH-CHI (Autor:in) / CHEN SHYI-JOU (Autor:in) / CHIA WEI-TSO (Autor:in) / WANG HSIN-YUN (Autor:in) / SHIH NENG-YAO (Autor:in) / LIU KO-JIUNN (Autor:in) / CHEN LI-TZONG (Autor:in)

    Erscheinungsdatum :

    2017-09-05


    Medientyp :

    Patent


    Format :

    Elektronische Ressource


    Sprache :

    Englisch


    Klassifikation :

    IPC:    C07K PEPTIDES , Peptide / A61K Zubereitungen für medizinische, zahnärztliche oder kosmetische Zwecke , PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES / B63B Schiffe oder sonstige Wasserfahrzeuge , SHIPS OR OTHER WATERBORNE VESSELS / B63H Schiffsantrieb oder Steuerung der Schiffe , MARINE PROPULSION OR STEERING